Valleywise Behavioral Health Center Maryvale

Type of Care

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Hospital inpatient/24-hour hospital inpatient Outpatient

Facility Type

Separate inpatient psychiatric unit of a general hospital

Pharmacotherapies

Chlorpromazine Fluphenazine Haloperidol Loxapine Perphenazine Prochlorperazine Thiothixene Trifluoperazine Aripiprazole Clozapine Lurasidone Olanzapine Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Treatment Approaches

Activity therapy Cognitive behavioral therapy Couples/family therapy Group therapy Individual psychotherapy Telemedicine/telehealth therapy Abnormal involuntary movement scale

Facility Operation (e.g., Private, Public)

Local, county, or community government

Payment/Insurance/Funding Accepted

County or local government funds Medicare Medicaid Other State funds Private health insurance State corrections or juvenile justice funds Cash or self-payment State mental health agency (or equivalent) funds

Special Programs/Groups Offered

Criminal justice (other than DUI/DWI)/Forensic clients Clients with co-occurring mental and substance use disorders Persons 18 and older with serious mental illness (SMI)

Assessment/Pre-treatment

Screening for tobacco use

Testing

Metabolic syndrome monitoring Laboratory testing

Recovery Support Services

Mentoring/peer support

Education and Counseling Services

Smoking/vaping/tobacco cessation counseling

Facility Smoking Policy

Smoking not permitted

Age Groups Accepted

Young Adults Seniors

Language Services

Spanish

Facility Vaping Policy

Vaping not permitted

Ancillary Services

Assertive community treatment Court-ordered outpatient treatment Family psychoeducation Case management service